These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 237405)

  • 21. Evaluation of beta-adrenolytic properties of N,N'-bis-(3-(p-methoxyphenoxy)-2-hydroxypropyl)-ethylenediamine and its N,N'-dimethyl derivative.
    Robak J; Grodzińska L
    Pol J Pharmacol Pharm; 1973; 25(3):253-7. PubMed ID: 4150018
    [No Abstract]   [Full Text] [Related]  

  • 22. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 23. Nitrilophenoxypropanolamines: influence of ring substitution on beta-receptor blockade.
    Mylecharane EJ; Raper C
    Eur J Pharmacol; 1974 Nov; 29(1):93-101. PubMed ID: 4154862
    [No Abstract]   [Full Text] [Related]  

  • 24. Sympathetic control of coronary and systemic hemodynamics in emotional stress in the conscious dog.
    Bergamaschi M; Shanks RG; Mandelli V
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():399-407. PubMed ID: 4157080
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow-release tablets in single and multiple doses.
    Regårdh CG; Johnsson G; Jordö L; Sölvell L
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):45-58. PubMed ID: 1079687
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biotransformation and pharmacokinetics of beta-receptor blockaders].
    Pfeifer S; Zimmer C
    Pharmazie; 1975 Oct; 30(10):625-33. PubMed ID: 685
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
    Bekes M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma renin activity after the use of a new beta-adrenergic blocking agent (I.C.I. 66,032).
    Aberg H
    Int J Clin Pharmacol; 1974 Mar; 9(2):98-100. PubMed ID: 4151244
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
    Vinceneux P; Canal M; Domart Y; Roux A; Cascio B; Orofiamma B; Larribaud J; Flouvat B; Carbon C
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative effects of several beta-adrenergic inhibitors on pulmonary resistance in guinea pigs].
    Giudicelli JF; Boissier JR; Dumas Y; Advenier C
    C R Seances Soc Biol Fil; 1973; 167(2):232-7. PubMed ID: 4153959
    [No Abstract]   [Full Text] [Related]  

  • 33. The central action of drugs affecting beta-adrenergic receptor. IV. The influence of intraventricularly administered drugs affecting beta-adrenergic receptor on blood pressure in rats.
    Kleinrok Z; Ksiazek A
    Pol J Pharmacol Pharm; 1975; 27(2):177-82. PubMed ID: 239397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats.
    Karppanen H; Lahovaara S; Mattila MJ
    Ann Med Exp Biol Fenn; 1973 Mar; 51(3):104-11. PubMed ID: 4149365
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetic parameters of bevantolol in volunteers.
    Vermeij P; van Brummelen P
    Eur J Clin Pharmacol; 1986; 30(3):375-7. PubMed ID: 2874033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
    Klempt HW; Bender F
    Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
    [No Abstract]   [Full Text] [Related]  

  • 37. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
    Noguchi Y; Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolism of two beta-adrenoceptor antagonists, alprenolol and metoprolol, in different species. In-vitro and in-vivo correlations.
    Skånberg I
    Acta Pharm Suec; 1980; 17(5):295-6. PubMed ID: 7223445
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of metoprolol and propranolol on hemodynamic effects induced by physical work and isoprenaline.
    Johnsson G; Nyberg G; Sölvell L
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):69-75. PubMed ID: 1094803
    [No Abstract]   [Full Text] [Related]  

  • 40. A survey of the pharmacological properties of metoprolol in animals and man.
    Ablad B; Borg KO; Carlsson E; EK L; Johnson G; Malmfors T; Regårdh CG
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):7-23. PubMed ID: 1094804
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.